2509 fundamentals
An in-depth look to QYUNS THERAPEUTICS CO LTD operating, investing, and financing activities
2509 free cash flow for H2 24 is -134.4 M HKD. For 2024, 2509 free cash flow was -214.08 M HKD and operating cash flow was -212.75 M HKD.
Q4 '22
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q4 '22
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM